Graham Capital Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,080
| Closed | -$33.1K | – | 1432 |
|
|
2025
Q1 | $33.1K | Buy |
3,080
+473
| +18% | +$5.09K | ﹤0.01% | 1210 |
|
|
2024
Q4 | $33.4K | Buy |
+2,607
| New | +$33.4K | ﹤0.01% | 1165 |
|
|
2024
Q2 | – | Sell |
-1,089
| Closed | -$48.6K | – | 1201 |
|
|
2024
Q1 | $48.6K | Sell |
1,089
-204
| -16% | -$9.1K | ﹤0.01% | 991 |
|
|
2023
Q4 | $50.2K | Buy |
+1,293
| New | +$50.2K | ﹤0.01% | 918 |
|